Welcome to our dedicated page for ACME UNITED SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ACME UNITED's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ACME UNITED's regulatory disclosures and financial reporting.
The Capital Management Corporation filed an amended Schedule 13G reporting its beneficial ownership of Acme United Corporation common stock as of 12/31/2025. The firm reports beneficial ownership of 540,341.30 shares, representing 14.2% of Acme United’s outstanding common stock.
The Capital Management Corporation has sole voting power over 534,966.30 shares and sole dispositive power over 540,341.30 shares, with no shared voting or dispositive power. The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Acme United.
Acme United Corporation completed an asset acquisition from SLED Distribution, LLC d/b/a "My Medic" and Rapid Medical, LLC, buying substantially all assets of their emergency and first aid products business. The maximum purchase price for the acquired assets is $18,700,000, including $14.6 million paid in cash at closing.
An additional $1,000,000 is contingent on achieving specified revenue milestones during the twelve months ended December 31, 2027, and $3.1 million is subject to a holdback primarily to cover potential indemnification claims. Acme acquired inventory, receivables, equipment, intellectual property, customer and supplier relationships, and certain contracts, while excluding cash, certain contracts, and other non-core items, and only assumed limited specified liabilities. The agreement includes customary representations, warranties, covenants, and indemnification provisions and is governed by Utah law.
Acme United (ACU) reported steady Q3 2025 results. Net sales were $49,063,000, up 2% year over year, with diluted EPS of $0.46 (basic $0.50). Gross margin improved to 39.1% from 38.5%, while SG&A rose to 33.0% of sales. Operating income was $3,007,000, slightly above last year. Net income was $1,903,000 versus $2,226,000 a year ago.
The U.S. segment grew modestly on first aid and medical products, Canada increased 5% (strength in first aid), and Europe rose 13% on e‑commerce school and office products. For the nine months, sales were $149,018,000 and diluted EPS held at $2.03.
Liquidity remained solid: operating cash flow reached $10,079,000 year to date, working capital increased to $76,619,000, and the current ratio improved to 4.47. The company extended its $65 million SOFR+1.75% revolving credit facility to May 31, 2027 and purchased a Mt. Pleasant, TN manufacturing and distribution center for approximately $6.0 million. Management disclosed a previously identified material weakness in IT general controls remains, with remediation expected by December 31, 2025.
Acme United Corporation filed a Form 8-K stating it issued a press release announcing financial results for the quarter ended September 30, 2025. The company furnished the release as Exhibit 99.1.
The filing lists Item 2.02 (Results of Operations and Financial Condition) and includes the press release dated October 21, 2025. Acme United’s common stock trades on the NYSE American under the symbol ACU.
ACME United Corp director Holden Richmond Y Jr reported an option exercise and share disposition. On September 5, 2025, he exercised employee stock options for 2,500 shares at $21.20 per share on a net cash settlement basis directly with the issuer, not involving issuance of any underlying common shares, and disposed of 2,500 common shares to the issuer at $44.36 per share. Following these transactions, he directly holds 15,250 common shares.
Rex Lynn Davidson, a director of Acme United Corp (ACU), reported exercising employee stock options on 08/12/2025 to acquire 2,500 shares of common stock at a price of $43.40 per share. Following the exercise, Davidson directly beneficially owned 29,000 shares. The Form 4 was signed on 08/14/2025. The filing shows a routine option exercise by an insider and records the updated direct ownership.
On August 12-13, 2025, Richmond Y. Holden Jr., a director of Acme United Corp (ACU), exercised employee stock options and completed related transactions. He exercised 2,500 options with a $43.40 exercise price (exercisable and executed 08/12/2025) producing 2,500 underlying shares, and exercised 2,500 options with a $22.60 exercise price (executed 08/13/2025) producing 2,500 underlying shares. Concurrently, 2,500 shares were acquired at $22.66 and 2,500 shares were disposed of via a net cash settlement at an effective price of $44.58, reflecting an exercise settled without issuing shares. Following these transactions, Mr. Holden beneficially owned 21,500 shares from derivative holdings and 15,250 shares direct after the net settlement, per the reporting table.
Brian Barker, a director of Acme United Corp (ACU), reported a derivative-to-equity transaction on 08/12/2025. The filing shows the exercise/acquisition of 2,500 shares underlying an employee stock option with an indicated price of $43.4 per share. After the reported transaction, Mr. Barker beneficially owned 19,000 shares. The Form 4 is signed by Brian Barker on 08/14/2025 and identifies his address in Shelton, CT.
Paul J. Conway, a director of Acme United Corp (ACU), reported a securities transaction on Form 4. The filing shows an employee stock option exercise on 08/12/2025 that acquired 2,500 shares of Common Stock at a conversion/exercise price of $43.4 per share. Following the reported transaction, Mr. Conway beneficially owns 7,500 shares. The Form 4 is signed and dated 08/14/2025 and lists Mr. Conway's address in Shelton, CT. No additional derivatives, dispositions, or indirect ownership details are included in the filing.
Susan H. Murphy, a director of Acme United Corp (ACU), exercised an employee stock option on 08/12/2025 to acquire 2,500 shares at an exercise price of $43.40 per share. The options became exercisable on 08/13/2025 and expire 08/12/2035. Following the transaction, Ms. Murphy beneficially owns 29,000 shares on a direct basis. The Form 4 was signed 08/14/2025 and reports the change required under Section 16.